Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical experience with subxyphoid pericardial decompression.

S C Ghosh, A J Larrieu, S G Ablaza

    International Surgery
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical Observations with New Amœbicidal Drugs Part I: Trials with Resotren.

    The Indian medical gazette·2017
    Same author

    Advances in the Development of Multimodal Imaging Agents for Nuclear/Near-infrared Fluorescence Imaging.

    Current medicinal chemistry·2015
    Same author

    A concealed small bowel perforation in an adult secondary to bicycle handlebar trauma.

    Annals of the Royal College of Surgeons of England·2013
    Same author

    The effect of GaAs(100) surface preparation on the growth of nanowires.

    Nanotechnology·2009
    Same author

    MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.

    Lung cancer (Amsterdam, Netherlands)·2009
    Same author

    Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.

    The Prostate·2007

    Subxyphoid pericardial decompression is a safe and effective treatment for pericardial effusion. Local anesthesia offers superior safety compared to general anesthesia, with no major complications or operative deaths.

    Area of Science:

    • Cardiology
    • Thoracic Surgery

    Background:

    • Pericardial effusion is a significant clinical condition requiring effective management.
    • Subxyphoid pericardial decompression has been utilized for decades in treating pericardial effusion.

    Purpose of the Study:

    • To evaluate the safety and efficacy of subxyphoid pericardial decompression for pericardial effusion.
    • To compare outcomes between local and general anesthesia for this procedure.

    Main Methods:

    • A retrospective analysis of 108 patients undergoing subxyphoid pericardial decompression between 1971 and 1981.
    • Patients were treated under local (63%) or general (37%) anesthesia.
    • Procedure involved fluid drainage, pericardial window creation, and biopsy.

    Main Results:

    Related Experiment Videos

    • Echocardiography was diagnostic in all cases.
    • Local anesthesia group had no operative deaths or major complications.
    • General anesthesia group had two operative deaths and one case of hemiplegia.
    • Recurrence rate was 4.6%, requiring further intervention.

    Conclusions:

    • Subxyphoid pericardial decompression under local anesthesia is a safe and effective primary treatment for pericardial effusion.
    • Local anesthesia is associated with better safety outcomes than general anesthesia for this procedure.